A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.
Saved in:
| Title: | A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis. |
|---|---|
| Authors: | Fleischmann RM; University of Texas Southwestern Medical Center, Dallas., Bliddal H; Bispebjerg-Frederiksberg Hospital and University of Copenhagen, Copenhagen, Denmark., Blanco FJ; Hospital Universitario A Coruña, La Coruña, Spain., Schnitzer TJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois., Peterfy C; Spire Sciences, Inc., Boca Raton, Florida., Chen S; AbbVie Inc., North Chicago, Illinois., Wang L; AbbVie Inc., North Chicago, Illinois., Feng S; AbbVie Inc., North Chicago, Illinois., Conaghan PG; University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds, UK., Berenbaum F; Sorbonne Université, INSERM, and AP-HP Hospital Saint-Antoine, Paris, France., Pelletier JP; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada., Martel-Pelletier J; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada., Vaeterlein O; Bioclinica, Hamburg, Germany., Kaeley GS; University of Florida College of Medicine., Liu W; AbbVie Inc., North Chicago, Illinois., Kosloski MP; AbbVie Inc., North Chicago, Illinois., Levy G; AbbVie Inc., North Chicago, Illinois., Zhang L; AbbVie Inc., North Chicago, Illinois., Medema JK; AbbVie Inc., North Chicago, Illinois., Levesque MC; AbbVie Inc., North Chicago, Illinois. |
| Source: | Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2019 Jul; Vol. 71 (7), pp. 1056-1069. Date of Electronic Publication: 2019 Jun 07. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30653843 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fleischmann+RM%22">Fleischmann RM</searchLink>; University of Texas Southwestern Medical Center, Dallas.<br /><searchLink fieldCode="AU" term="%22Bliddal+H%22">Bliddal H</searchLink>; Bispebjerg-Frederiksberg Hospital and University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Blanco+FJ%22">Blanco FJ</searchLink>; Hospital Universitario A Coruña, La Coruña, Spain.<br /><searchLink fieldCode="AU" term="%22Schnitzer+TJ%22">Schnitzer TJ</searchLink>; Northwestern University Feinberg School of Medicine, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Peterfy+C%22">Peterfy C</searchLink>; Spire Sciences, Inc., Boca Raton, Florida.<br /><searchLink fieldCode="AU" term="%22Chen+S%22">Chen S</searchLink>; AbbVie Inc., North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; AbbVie Inc., North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Feng+S%22">Feng S</searchLink>; AbbVie Inc., North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Conaghan+PG%22">Conaghan PG</searchLink>; University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Berenbaum+F%22">Berenbaum F</searchLink>; Sorbonne Université, INSERM, and AP-HP Hospital Saint-Antoine, Paris, France.<br /><searchLink fieldCode="AU" term="%22Pelletier+JP%22">Pelletier JP</searchLink>; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Martel-Pelletier+J%22">Martel-Pelletier J</searchLink>; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Vaeterlein+O%22">Vaeterlein O</searchLink>; Bioclinica, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kaeley+GS%22">Kaeley GS</searchLink>; University of Florida College of Medicine.<br /><searchLink fieldCode="AU" term="%22Liu+W%22">Liu W</searchLink>; AbbVie Inc., North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Kosloski+MP%22">Kosloski MP</searchLink>; AbbVie Inc., North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Levy+G%22">Levy G</searchLink>; AbbVie Inc., North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; AbbVie Inc., North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Medema+JK%22">Medema JK</searchLink>; AbbVie Inc., North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Levesque+MC%22">Levesque MC</searchLink>; AbbVie Inc., North Chicago, Illinois. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101623795%22">Arthritis & rheumatology (Hoboken, N.J.)</searchLink> [Arthritis Rheumatol] 2019 Jul; Vol. 71 (7), pp. 1056-1069. <i>Date of Electronic Publication: </i>2019 Jun 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101623795 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-5205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223265191%22">23265191 </searchLink><i>NLM ISO Abbreviation: </i>Arthritis Rheumatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30653843 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/art.40840 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1056 Titles: – TitleFull: A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fleischmann RM – PersonEntity: Name: NameFull: Bliddal H – PersonEntity: Name: NameFull: Blanco FJ – PersonEntity: Name: NameFull: Schnitzer TJ – PersonEntity: Name: NameFull: Peterfy C – PersonEntity: Name: NameFull: Chen S – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Feng S – PersonEntity: Name: NameFull: Conaghan PG – PersonEntity: Name: NameFull: Berenbaum F – PersonEntity: Name: NameFull: Pelletier JP – PersonEntity: Name: NameFull: Martel-Pelletier J – PersonEntity: Name: NameFull: Vaeterlein O – PersonEntity: Name: NameFull: Kaeley GS – PersonEntity: Name: NameFull: Liu W – PersonEntity: Name: NameFull: Kosloski MP – PersonEntity: Name: NameFull: Levy G – PersonEntity: Name: NameFull: Zhang L – PersonEntity: Name: NameFull: Medema JK – PersonEntity: Name: NameFull: Levesque MC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2019 Jul Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2326-5205 Numbering: – Type: volume Value: 71 – Type: issue Value: 7 Titles: – TitleFull: Arthritis & rheumatology (Hoboken, N.J.) Type: main |
| ResultId | 1 |